Literature DB >> 19651590

Management of childhood onset nephrotic syndrome.

Debbie S Gipson1, Susan F Massengill, Lynne Yao, Shashi Nagaraj, William E Smoyer, John D Mahan, Delbert Wigfall, Paul Miles, Leslie Powell, Jen-Jar Lin, Howard Trachtman, Larry A Greenbaum.   

Abstract

The therapeutic approach to childhood nephrotic syndrome is based on a series of studies that began with an international collaborative effort sponsored by the International Study of Kidney Disease in Children in 1967. The characteristics of children presenting with nephrotic syndrome have changed over recent decades with greater frequency of the challenging condition focal segmental glomerulosclerosis and a greater prevalence of obesity and diabetes mellitus, which may be resistant to glucocorticoids in the former and exacerbated by long-term glucocorticoid therapy in the latter 2 conditions. The Children's Nephrotic Syndrome Consensus Conference was formed to systematically review the published literature and generate a children's primary nephrotic syndrome guideline for use in educational, therapeutic, and research venues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651590     DOI: 10.1542/peds.2008-1559

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  99 in total

1.  GLCCI1 single nucleotide polymorphisms in pediatric nephrotic syndrome.

Authors:  Hae Il Cheong; Hee Gyung Kang; Johannes Schlondorff
Journal:  Pediatr Nephrol       Date:  2012-06-04       Impact factor: 3.714

2.  Factors influencing cardiovascular risk following termination of glucocorticoid therapy for nephrotic syndrome.

Authors:  Akio Nakamura; Ryo Niimi; Kumiko Kurosaki; Yukishige Yanagawa
Journal:  Clin Exp Nephrol       Date:  2010-07-17       Impact factor: 2.801

3.  Proteomic analysis indicates altered expression of plasma proteins in a rat nephropathy model.

Authors:  Si Ai; Jian Zheng; Qing Lin; Rongyan Chen
Journal:  Clin Exp Nephrol       Date:  2012-07-07       Impact factor: 2.801

4.  Increasing frequency of acute kidney injury amongst children hospitalized with nephrotic syndrome.

Authors:  Michelle N Rheault; Chang-Ching Wei; David S Hains; Wei Wang; Bryce A Kerlin; William E Smoyer
Journal:  Pediatr Nephrol       Date:  2013-09-14       Impact factor: 3.714

5.  NOX-mediated impairment of PDGF-induced DNA synthesis in peripheral blood lymphocytes of children with idiopathic nephrotic syndrome.

Authors:  Amal Al-Eisa; Gursev S Dhaunsi
Journal:  Pediatr Res       Date:  2017-06-14       Impact factor: 3.756

6.  Early and frequent development of ocular hypertension in children with nephrotic syndrome.

Authors:  Emi Kawaguchi; Kenji Ishikura; Riku Hamada; Yoshinobu Nagaoka; Yoshihiko Morikawa; Tomoyuki Sakai; Yuko Hamasaki; Hiroshi Hataya; Eiichiro Noda; Masaru Miura; Takashi Ando; Masataka Honda
Journal:  Pediatr Nephrol       Date:  2014-05-24       Impact factor: 3.714

7.  Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.

Authors:  Om P Mishra; Ravindra Kumar; Gopeshwar Narayan; Pradeep Srivastava; Abhishek Abhinay; Rajniti Prasad; Ankur Singh; Vineeta V Batra
Journal:  Pediatr Nephrol       Date:  2017-02-16       Impact factor: 3.714

8.  Cyclophosphamide followed by mizoribine as maintenance therapy against refractory steroid-dependent nephrotic syndrome.

Authors:  Shuichi Ito; Hirokazu Ikeda; Tomonori Harada; Koichi Kamei; Eihiko Takahashi
Journal:  Pediatr Nephrol       Date:  2011-06-28       Impact factor: 3.714

9.  Distinct metalloproteinase excretion patterns in focal segmental glomerulosclerosis.

Authors:  Kimberly A Czech; Michael Bennett; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2011-07-01       Impact factor: 3.714

10.  Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy.

Authors:  Yoshitsugu Kaku; Yasufumi Ohtsuka; Yasuhiro Komatsu; Toshiyuki Ohta; Takuhito Nagai; Hiroshi Kaito; Shuji Kondo; Yohei Ikezumi; Seiji Tanaka; Shinsuke Matsumoto; Mayumi Sako; Kazushi Tsuruga; Koichi Nakanishi; Koichi Kamei; Hiroshi Saito; Shuichiro Fujinaga; Yuko Hamasaki; Hiroko Chikamoto; Kenji Ishikura; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2015-02       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.